Integrative approaches for cardiovascular disease

Nutrition in Clinical Practice

Volumn 24, Issue 6, 2009, Pages 701-708

  Guarneri, Mimi ^a   Mercado, Nestor ^a   Suhar, Christopher ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

Cardiology; Complementary therapies; Integrative medicine; Prevention

Indexed keywords

CHOLESTIN; CRATAEGUS EXTRACT; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM; MANNAN; OMEGA 3 FATTY ACID; PYRIDOXINE; RESVERATROL; RIBOSE; SITOSTANOL; UBIDECARENONE; VITAMIN D;

ALTERNATIVE MEDICINE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIET SUPPLEMENTATION; DYSLIPIDEMIA; EXERCISE; HEART ARRHYTHMIA; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MEDITERRANEAN DIET; MYOPATHY; PRIMARY PREVENTION; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SECONDARY PREVENTION; VITAMIN D DEFICIENCY;

CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; EXERCISE; HEALTH BEHAVIOR; HUMANS; INTEGRATIVE MEDICINE; LIFE STYLE; RISK FACTORS; UNITED STATES;

EID: 74549209100     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533609343453     Document Type: Review

References (45)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
2. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884-1890.
3. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499-510.
4. Vogel JHK, Krucoff MW, eds. Integrative Cardiology: Complementary and Alternative Medicine for the Heart. New York: McGraw-Hill; 2007.
5. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238-1245.
6. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350. (Pubitemid 32378388)
7. Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79:350-354.
8. Campbell TC, Parpia B, Chen J. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study. Am J Cardiol. 1998;82:18-21.
9. Chen J, Campbell TC, Li J, Peto R, eds. Diet, Lifestyle and Mortality in China. Oxford, UK: Oxford University Press; 1990.
10. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998;97:2099-2100.
11. Ascherio A. Epidemiologic studies on dietary fats and coronary heart disease. Am J Med. 2002;113(suppl 9B):9S-12S.
12. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337: 1491-1499.
13. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779-785.
14. Singh RB, Dubnov G, Niaz MA, et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet. 2002;360:1455-1461.
15. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569-2578.
16. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994-2000.
17. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116: 682-692.
18. Hambrecht R, Walther C, Mobius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004;109:1371-1378. (Pubitemid 38387823)
19. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.
20. Mittleman MA, Maclure M, Sherwood JB, et al. Triggering of acute myocardial infarction onset by episodes of anger. Circulation. 1995;92:1720-1725.
21. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999-1005.
22. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818-1823.
23. Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000; 160:1354-1360.
24. Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA. 2005;293:1626-1634.
25. Schneider RH, Alexander CN, Staggers F, et al. Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension. Am J Cardiol. 2005;95:1060-1064.
26. Dusseldorp E, van Elderen T, Maes S, Meulman J, Kraaij V. A meta-analysis of psychoeducational programs for coronary heart disease patients. Health Psychol. 1999;18:506-519.
27. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006;166:1218-1224.
28. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulnessbased stress reduction and health benefits: a meta-analysis. J Psychosom Res. 2004;57:35-43.
29. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29:448-474.
30. Tacon AM, McComb J, Caldera Y, Randolph P. Mindfulness meditation, anxiety reduction, and heart disease: a pilot study. Fam Community Health. 2003;26:25-33.
31. Robert-McComb JJ, Tacon A, Randolph P, Caldera Y. A pilot study to examine the effects of a mindfulness-based stress-reduction and relaxation program on levels of stress hormones, physical functioning, and submaximal exercise responses. J Altern Complement Med. 2004;10:819-827.
32. Siegel JM. Stressful life events and use of physician services among the elderly: the moderating role of pet ownership. J Pers Soc Psychol. 1990;58:1081-1086.
33. Headey B. Health benefits and health cost savings due to pets: preliminary results from an Australian national survey. Soc Indicators Res. 1999;47:233-243.
34. Anderson WP, Reid CM, Jennings GL. Pet ownership and risk factors for cardiovascular disease. Med J Aust. 1992;157:298-301.
35. Friedmann E, Thomas SA, Stein PK, Kleiger RE. Relation between pet ownership and heart rate variability in patients with healed myocardial infarcts. Am J Cardiol. 2003;91:718-721.
36. Kshettry VR, Carole LF, Henly SJ, Sendelbach S, Kummer B. Complementary alternative medical therapies for heart surgery patients: feasibility, safety, and impact. Ann Thorac Surg. 2006;81: 201-205.
37. Gay MC. Effectiveness of hypnosis in reducing mild essential hypertension: a one-year follow-up. Int J Clin Exp Hypn. 2007;55:67-83.
38. Hippel CV, Hole G, Kaschka WP. Autonomic profile under hypnosis as assessed by heart rate variability and spectral analysis. Pharmacopsychiatry. 2001;34:111-113.
39. Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback. 2000;25:177-191.
40. Nakao M, Nomura S, Shimosawa T, et al. Clinical effects of blood pressure biofeedback treatment on hypertension by auto-shaping. Psychosom Med. 1997;59:331-338.
41. Nakao M, Nomura S, Shimosawa T, Fujita T, Kuboki T. Blood pressure biofeedback treatment of white-coat hypertension. J Psychosom Res. 2000;48:161-169.
42. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
43. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993;88:927-934.
44. Del Pozo JM, Gevirtz RN, Scher B, Guarneri E. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J. 2004;147:E11.
45. Yeh GY, Wood MJ, Lorell BH, et al. Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med. 2004;117:541-548.